Patents Assigned to INSERM (Institut de la Sante et de la Recherche Medicale)
  • Diagnostic of heart failure
    Patent number: 11061037
    Abstract: Disclosed herein is a method for classifying a patient at risk for heart failure, wherein the method comprises the steps of (i) measuring the concentration of IGFBP2 in a sample obtained from the patient and (ii) comparing the concentration of IGFBP2 measured in step (i) to a control value derived from the concentration of IGFBP2 in samples from patients who are at particular stages of heart failure and/or to a control value derived from the concentration of IGFBP2 in blood samples from healthy patients.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: July 13, 2021
    Assignees: INSERM (INSTITUT DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PAUL SABATIER TOULOUSE III, CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Philippe Rouet, Fatima Smih-Rouet, Franck Desmoulin, Michel Galinier
  • COMPOSITIONS AND METHODS FOR INCREASING VASCULARIZATION
    Publication number: 20130237477
    Abstract: Disclosed are methods of increasing vascularization in a tissue by administering a neublastin polypeptide to a mammal exhibiting impaired or inadequate blood flow in the tissue. The methods can be used to in the treatment or prevention of a disorder characterized by impaired or inadequate blood flow or to increase vascularization in an organ that has been transplanted into a subject.
    Type: Application
    Filed: November 16, 2012
    Publication date: September 12, 2013
    Applicants: INSERM (Institut de la Sante et de la Recherche Medicale), BIOGEN IDEC MA INC.
    Inventors: Anthony Rossomando, Jean-Sebastien Silvestre, Radia Tamarat